Atlas Trials

Antithrombotic Activities of Sotagliflozin vs. Empagliflozin

Clinical trial NCT06618976 · COMPLETED

Trial details

NCT number
NCT06618976
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Thrombosis
Start date
2025-02-25
Primary completion
2026-02-10
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.